Copyright
©The Author(s) 2022.
World J Orthop. Mar 18, 2022; 13(3): 289-296
Published online Mar 18, 2022. doi: 10.5312/wjo.v13.i3.289
Published online Mar 18, 2022. doi: 10.5312/wjo.v13.i3.289
Cases | Smear microscopy | Culture | Gene Xpert | ATT course (in mo) | Outcome (SF-12) | CRS category | |
PCS-12 | MCS-12 | ||||||
Case No. 1 | Negative | No growth | Positive | 12 | 48.76 | 55.50 | Probable OATB case |
Case No. 2 | Negative | Positive | Positive | Lost to follow-up | Confirmed OATB case | ||
Case No. 3 | Negative | No growth | Positive | 15 | 46.03 | 56.9 | Probable OATB case |
Case No. 4 | Negative | No growth | Positive | Lost to follow-up | Probable OATB case | ||
Case No. 5 | Negative | No growth | Positive | Lost to follow-up | Probable OATB case | ||
Case No. 6 | Positive | No growth | Positive | Lost to follow-up | Probable OATB case | ||
Case No. 7 | Negative | No growth | Positive | 24 | 56.57 | 60.75 | Probable OATB case |
Case No. 8 | Negative | No growth | Positive | 24 | 46.03 | 56.9 | Probable OATB case |
Case No. 9 | Negative | No growth | Positive | 6 | 48.60 | 33.57 | Probable OATB case |
Case No. 10 | Positive | No growth | Positive | Lost to follow-up | Probable OATB case | ||
Case No. 11 | Negative | No growth | Positive | Lost to follow-up | Probable OATB case | ||
Case No. 12 | Negative | No growth | Positive | Lost to follow-up | Probable OATB case | ||
Case No. 13 | Negative | No growth | Positive | Lost to follow-up | Probable OATB case | ||
Case No. 14 | Positive | No growth | Positive | Lost to follow-up | Probable OATB case | ||
Case No. 15 | Positive | Contamination | Positive | Lost to follow-up | Probable OATB case | ||
Case No. 16 | Negative | Contamination | Positive | Lost to follow-up | Probable OATB case | ||
Case No. 17 | Negative | No growth | Positive | 6 | 56.57 | 60.75 | Probable OATB case |
Case No. 18 | Negative | No growth | Positive | Lost to follow-up | Probable OATB case | ||
Case No. 19 | Negative | No growth | Positive | 6 | 52.23 | 56.51 | Probable OATB case |
Case No. 20 | Negative | No growth | Positive | 21 | 52.23 | 56.51 | Probable OATB case |
Case No. 21 | Negative | No growth | Positive | 15 | 52.23 | 53.63 | Probable OATB case |
Case No. 22 | Positive | Contamination | Positive | 12 | 56.57 | 60.75 | Probable OATB case |
Case No. 23 | Negative | No growth | Positive | 15 | 48.60 | 33.57 | Probable OATB case |
Case No. 24 | Negative | No growth | Positive | Lost to follow-up | Probable OATB case | ||
Case No. 25 | Positive | Positive | Positive | Lost to follow-up | Confirmed OATB case | ||
Case No. 26 | Negative | No growth | Positive | 12 | 51.81 | 48.67 | Probable OATB case |
Case No. 27 | Negative | Positive | Positive | 12 | 48.76 | 55.50 | Confirmed OATB case |
Case No. 28 | Negative | No growth | Positive | 6 | 56.57 | 60.75 | Probable OATB case |
Case No. 29 | Negative | No growth | Positive | Lost to follow-up | Probable OATB case | ||
Case No. 30 | Negative | No growth | Positive | 12 | 51.81 | 48.67 | Probable OATB case |
Case No. 31 | Negative | No growth | Positive | Lost to follow-up | Probable OATB case | ||
Case No. 32 | Negative | No growth | Positive | 12 | 40.76 | 40.94 | Probable OATB case |
Case No. 33 | Negative | No growth | Positive | Lost to follow-up | Probable OATB case | ||
Case No. 34 | Negative | Positive | Positive | 2 | 28.93 | 40.32 | Confirmed OATB case |
Case No. 35 | Negative | No growth | Positive | 1.5 | 28.93 | 40.32 | Probable OATB case |
Case No. 36 | Negative | Positive | Negative | 12 | 48.76 | 55.50 | Confirmed OATB case |
Case No. 37 | Negative | No growth | Negative | 1.5 | 28.93 | 40.32 | Possible OATB case |
Characteristics | Cases (n = 37) | |
Age group (yr) | 0 - 10 | 1 (2.7) |
11 - 20 | 5 (13.6) | |
21 – 30 | 10 (27.0) | |
31 - 40 | 6 (16.2) | |
41- 50 | 6 (16.2) | |
51 - 60 | 6 (16.2) | |
> 60 | 3 (8.1) | |
Sex | Male | 19 (51.4) |
Female | 18 (48.6) | |
Site if OATB | Knee | 8 (21.6) |
Spine | 20 (54.1) | |
Elbow | 1 (2.7) | |
Wrist | 1 (2.7) | |
Psoas abscess | 7 (18.9) |
Methods | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | Kappa statistics (% agreement) |
Gene Xpert | 94.6 | 100.0 | 94.6 | 100.0 | 95.0 |
Culture | 13.5 | 100.0 | 13.5 | 100.0 | 20.0 |
Smear microscopy | 16.2 | 100.0 | 16.2 | 100.0 | 22.5 |
- Citation: Mohanty M, Mishra B, Jain M, Karaniveed Puthiyapura L. Diagnostic role of Xpert-MTB RIF assay in osteoarticular tuberculosis: A retrospective study. World J Orthop 2022; 13(3): 289-296
- URL: https://www.wjgnet.com/2218-5836/full/v13/i3/289.htm
- DOI: https://dx.doi.org/10.5312/wjo.v13.i3.289